Dr. Neil Dunavin is a hematologist who cares for patients with leukemia, including those receiving stem cell transplantation. He also treats patients with myelodysplastic syndromes (bone marrow disorders that cause abnormalities in the blood cells produced there), myeloproliferative neoplasms (blood cancers that occur when the bone marrow overproduces one of the blood cell types), aplastic anemia (when the bone marrow stops making enough new blood cells) and bone marrow failure (when the body's needs for new healthy blood cells are not being met).
Dunavin's research focuses on treatments for blood and bone marrow cancers. He has been involved in numerous clinical trials to evaluate promising therapies. He is also interested in quality improvement for patient care in hematology and stem cell transplantation.
Dunavin earned his medical degree at the University of Kansas School of Medicine. He completed a residency in internal medicine at the Ohio State University Wexner Medical Center, where he served as chief resident. He completed a fellowship in hematology and stem cell transplantation at the National Institutes of Health Clinical Center. He also has a master's degree in clinical research from the Duke University School of Medicine.
Dunavin has lectured and published extensively in the field of hematology. He is a member of the American Society of Hematology, American Society for Transplantation and Cellular Therapy, International Society for Cellular Therapy and American Society of Gene & Cell Therapy.
Dunavin is passionate about providing health care through volunteer clinics, both domestically and abroad. He has participated in medical outreach to two countries in East Africa and works with hematology trainees at Muhimbili National Hospital in Dar es Salaam, Tanzania.